- All sections
- C - Chemistry; metallurgy
- C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture
- C12P 21/08 - Monoclonal antibodies
Patent holdings for IPC class C12P 21/08
Total number of patents in this class: 4383
10-year publication summary
|
248
|
282
|
176
|
201
|
176
|
233
|
199
|
132
|
96
|
23
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Chugai Seiyaku Kabushiki Kaisha | 1259 |
139 |
| Genentech, Inc. | 3742 |
75 |
| Daiichi Sankyo Company, Limited | 1829 |
71 |
| F. Hoffmann-La Roche AG | 7958 |
56 |
| Amgen Inc. | 3779 |
56 |
| Regeneron Pharmaceuticals, Inc. | 3650 |
52 |
| The Regents of the University of California | 18943 |
46 |
| Kyowa Hakko Kirin Co., Ltd. | 285 |
43 |
| Xencor, Inc. | 403 |
43 |
| Astellas Pharma Inc. | 1145 |
42 |
| Toray Industries, Inc. | 6652 |
41 |
| MedImmune, LLC | 467 |
35 |
| Osaka University | 3143 |
35 |
| Abbvie Inc. | 1808 |
32 |
| MacroGenics, Inc. | 267 |
30 |
| The University of Tokyo | 3903 |
30 |
| Janssen Biotech, Inc. | 1347 |
29 |
| Novartis AG | 11238 |
27 |
| Takeda Pharmaceutical Company Limited | 2961 |
23 |
| Merck Sharp & Dohme LLC | 3689 |
22 |
| Other owners | 3456 |